No authors listed. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 2, 349–360 (1988).
Antithrombotic Trialists’ (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373, 1849–1860 (2009).
Schomig, A. et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N. Engl. J. Med. 334, 1084–1089 (1996).
Urban, P. et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the Multicenter Aspirin and Ticlopidine Trial after Intracoronary Stenting (MATTIS). Circulation 98, 2126–2132 (1998).
Steinhubl, S. R. et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288, 2411–2420 (2002).
Wiviott, S. D. et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 357, 2001–2015 (2007).
Wallentin, L. et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 361, 1045–1057 (2009).
Palmerini, T. et al. Bleeding-related deaths in relation to the duration of dual-antiplatelet therapy after coronary stenting. J. Am. Coll. Cardiol. 69, 2011–2022 (2017).
Gawaz, M., Langer, H. & May, A. E. Platelets in inflammation and atherogenesis. J. Clin. Invest. 115, 3378–3384 (2005).
CAS PubMed PubMed Central Google Scholar
Stark, K. & Massberg, S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat. Rev. Cardiol. 18, 666–682 (2021).
PubMed PubMed Central Google Scholar
Gawaz, M., Neumann, F. J., Ott, I., Schiessler, A. & Schomig, A. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation 93, 229–237 (1996).
Ott, I., Neumann, F. J., Gawaz, M., Schmitt, M. & Schomig, A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 94, 1239–1246 (1996).
Gawaz, M. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc. Res. 61, 498–511 (2004).
Weber, C. Platelets and chemokines in atherosclerosis: partners in crime. Circ. Res. 96, 612–616 (2005).
Libby, P. Mechanisms of acute coronary syndromes and their implications for therapy. N. Engl. J. Med. 368, 2004–2013 (2013).
Ziegler, M., Wang, X. & Peter, K. Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target. Cardiovasc. Res. 115, 1178–1188 (2019).
CAS PubMed PubMed Central Google Scholar
Rohlfing, A. K. et al. ACKR3 regulates platelet activation and ischemia-reperfusion tissue injury. Nat. Commun. 13, 1823 (2022).
CAS PubMed PubMed Central Google Scholar
Kaplan, Z. S. & Jackson, S. P. The role of platelets in atherothrombosis. Hematol. Am. Soc. Hematol. Educ. Program. 2011, 51–61 (2011).
Davi, G. & Patrono, C. Platelet activation and atherothrombosis. N. Engl. J. Med. 357, 2482–2494 (2007).
Ruggeri, Z. M. Platelets in atherothrombosis. Nat. Med. 8, 1227–1234 (2002).
Nieswandt, B. et al. Glycoprotein VI but not α2β1 integrin is essential for platelet interaction with collagen. EMBO J. 20, 2120–2130 (2001).
CAS PubMed PubMed Central Google Scholar
Gawaz, M. & Vogel, S. Platelets in tissue repair: control of apoptosis and interactions with regenerative cells. Blood 122, 2550–2554 (2013).
Gawaz, M. P. et al. Ligand bridging mediates integrin alpha IIb beta 3 (platelet GPIIB-IIIA) dependent homotypic and heterotypic cell-cell interactions. J. Clin. Invest. 88, 1128–1134 (1991).
CAS PubMed PubMed Central Google Scholar
Massberg, S. et al. Platelets secrete stromal cell-derived factor 1α and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J. Exp. Med. 203, 1221–1233 (2006).
CAS PubMed PubMed Central Google Scholar
Henn, V. et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391, 591–594 (1998).
Massberg, S. et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J. Exp. Med. 196, 887–896 (2002).
CAS PubMed PubMed Central Google Scholar
Burger, P. C. & Wagner, D. D. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 101, 2661–2666 (2003).
Gawaz, M. et al. Vitronectin receptor (αvβ3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation 96, 1809–1818 (1997).
Massberg, S. et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J. Exp. Med. 197, 41–49 (2003).
CAS PubMed PubMed Central Google Scholar
Massberg, S. et al. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 112, 1180–1188 (2005).
Bultmann, A. et al. Impact of glycoprotein VI and platelet adhesion on atherosclerosis–a possible role of fibronectin. J. Mol. Cell Cardiol. 49, 532–542 (2010).
Seizer, P. et al. EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI–EMMPRIN interaction. Thromb. Haemost. 101, 682–686 (2009).
Schonberger, T. et al. The dimeric platelet collagen receptor GPVI-Fc reduces platelet adhesion to activated endothelium and preserves myocardial function after transient ischemia in mice. Am. J. Physiol. Cell Physiol. 303, C757–C766 (2012).
Huo, Y. et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat. Med. 9, 61–67 (2003).
Robbins, C. S. et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat. Med. 19, 1166–1172 (2013).
CAS PubMed PubMed Central Google Scholar
Zeibig, S. et al. Effect of the oxLDL binding protein Fc-CD68 on plaque extension and vulnerability in atherosclerosis. Circ. Res. 108, 695–703 (2011).
Chatterjee, M. et al. Regulation of oxidized platelet lipidome: implications for coronary artery disease. Eur. Heart J. 38, 1993–2005 (2017).
Siegel-Axel, D., Daub, K., Seizer, P., Lindemann, S. & Gawaz, M. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc. Res. 78, 8–17 (2008).
Harm, T. et al. Acute coronary syndrome is associated with a substantial change in the platelet lipidome. Cardiovasc. Res. 118, 1904–1916 (2022).
Chatterjee, M. et al. Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7. Cell Death Dis. 6, e1989 (2015).
CAS PubMed PubMed Central Google Scholar
Burgstahler, C. et al. Elevated coronary calcium scores are associated with higher residual platelet aggregation after clopidogrel treatment in patients with stable angina pectoris. Int. J. Cardiol. 135, 132–135 (2009).
Yun, K. H. et al. Relationship between platelet reactivity and culprit lesion morphology: an assessment from the ADAPT-DES intravascular ultrasound substudy. JACC Cardiovasc. Imaging 9, 849–854 (2016).
Matetzky, S. et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109, 3171–3175 (2004).
Trip, M. D., Cats, V. M., van Capelle, F. J. & Vreeken, J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N. Engl. J. Med. 322, 1549–1554 (1990).
Geisler, T. et al. Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions. Eur. Heart J. 31, 59–66 (2010).
Muller, I. et al. Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb. Haemost. 89, 783–787 (2003).
留言 (0)